Natalia I. Ryzhova

Natalia I. Ryzhova

Auto-generated profile, based on publicly available information

Natalia I. Ryzhova

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Лечащий врач
Verified
Journal Article
Closed access
VLV.F. Levshin
V.F. Levshin
NSN.I. Slepchenko
N.I. Slepchenko
NRN.I. Ryzhova
N.I. Ryzhova
LSL.A. Savluchinskaya
L.A. Savluchinskaya
LSL.G. Solenova
L.G. Solenova
The purpose of this medical and social research is to study the knowledge, attitude and participation of the population in the preventive and screening examinations and to analyze the real practice and results of the programе of preventive examinations. For the period from May 2020 to January 2022, the special survey of 461 adults of Moscow residents aged 18-79 years was conducted. The median sample age was 45 years. The number of women in the study sample was 284 (61.6%), men – 177 (38.4%). The survey using a unified and structured questionnaire was conducted through individual and anonymous interviews. Statistical processing of data was carried out by methods of descriptive statistics and one-factor analysis of variance. 33.2% (95% CI 28.8-37.6) of respondents in the study sample did not know or had misconceptions about the purposes of preventive and screening examinations. The majority, 65.5% (95% CI 61.07-69.9), had limited or insufficient knowledge, with only 1.3% (95% CI 0.25-2.35) of respondents having relatively sufficient knowledge. 40.6% (95% CI 36.03-45.07) of the respondents knew nothing about the scientifically proven measures and methods for cancer prevention and only 19.1% (95% CI 15.44-22.76) had relatively sufficient knowledge. Less than half of the respondents, 43.8% (95% CI 39.18-48.42). Had sufficient motivation and readiness to undergo preventive examinations. Most of the persons who underwent medical examinations received an incomplete set of studies and measures indicated for preventive examination. Most often, questionnaires, measurement of body mass index, analysis of feces for occult blood, examination for the detection of visual and other localizations of oncological diseases and individual preventive counseling are not performed. The majority of respondents either never underwent the preventive examination or received an incomplete set of studies and measures indicated for preventive medical examination. Such inadequate implementation of the preventive survey program for population has a small effect, or even the absence of it. The main reasons for the ineffective introduction of preventive examination are named and approaches to the development and improvement of the preventive examination program. in the health care system are proposed.

15 May 2021 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
VDV. P. Deryagina
V. P. Deryagina
NRN. I. Rizhova
N. I. Rizhova
LSL. A. Savluchinskaya
L. A. Savluchinskaya
KKKirill Kirsanov
Kirill Kirsanov
Introduction. Nitric oxide (NO) produced by NO synthases (NOS) is involved in the regulation of vital physiological functions. At the same time, NO and NOS are involved in events associated with the tumor process: mutagenesis, proliferation, apoptosis, angiogenesis, etc., exerting a multidirectional effect on the tumor.Objectives – analyze and summarize literature data concerning the role of NO and endothelial NOS (eNOS) in the initiation and progression of tumors, as well as in the inhibition of tumor growth.Materials and methods. In preparing the review, publications of information bases of biomedical literature were used: SciVerse Scopus (538), PubMed (1327), Web of Science (905), Russian Science Citation Index (125).Results. The molecular mechanisms of the action of NO and its derivatives on the initiation and progression of carcinogenesis have been explored. Numerous factors and conditions regulating the activity of eNOS in health and tumor growth have been analyzed. The molecular signaling pathways through which the pro-tumor effects of NO and eNOS, stimulating angiogenesis, lymphangiogenesis, are realized, including through the mobilization of stem cells, are considered.Conclusion. Nitric oxide produced by activated eNOS promotes tumor progression by increasing the proliferation of tumor cells, enhancing the action of pro-angiogenic factors, stimulating angiogenesis, lymphangiogenesis, and metastasis. Selective inhibition of increased eNOS activity may be a promising therapeutic approach aimed at reducing metastasis and tumor growth.

1 August 2014 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
TST. I. Shirshova
T. I. Shirshova
IBI. V. Beshlei
I. V. Beshlei
VDV. P. Deryagina
V. P. Deryagina
NRN. I. Ryzhova
N. I. Ryzhova

9 December 2024 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
MYMarianna G Yakubovskaya
Marianna G Yakubovskaya
TFT. I. Fetisov
T. I. Fetisov
LSL. G. Solenova
L. G. Solenova
NRN. I. Ryzhova
N. I. Ryzhova
ALA. V. Lokhonina
A. V. Lokhonina
VAV. V. Aginova
V. V. Aginova
Recent development of molecular and genetic technologies has demonstrated at the molecular level the co-evolutionary principles of interaction between microbiota, virome and the host organism, as well as the role of microorganisms and viruses both in maintaining physiological homeostasis and in the development of various diseases, including malignant neoplasms. The presented review is devoted to the analysis and generalization of modern data on microorganisms and viruses inhabiting the human body, their role in the processes of initiation, promotion and progression of carcinogenesis. The review provides information on known oncogenic viruses and microorganisms according to the modern classification of carcinogenic agents of the International Agency for Research on Cancer. Mechanistic data on the procarcinogenic effect of microbiota and virome are considered in accordance with the modern concept of key characteristics of a carcinogenic agent. Particular attention is paid to the analysis of data on the influence of microbiota and virome on the immunity of the host organism, including both the first results of immunotherapy with Coley toxin of soft tissue sarcomas and osteosarcomas, and data on the influence of individual types of microorganisms on the formation of the immunocompetent cell profile of the host organism. In addition, the influence of intratumor and intracellular microbiota, respectively, on the microenvironment of tumor cells and cellular signaling, including in solid tumors that have no contact with the external environment are also discussed. The data presented are important in terms of the holobiota concept, showing the interdependent existence of the human body, microorganisms and viruses, to improve the prevention and therapy of malignant neoplasms.

19 December 2024 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
LSL. G. Solenova
L. G. Solenova
NRN. I. Ryzhova
N. I. Ryzhova
GBGennady A. Belitsky
Gennady A. Belitsky
IAIrina Antonova
Irina Antonova
KKKirill Kirsanov
Kirill Kirsanov
MYMarianna G Yakubovskaya
Marianna G Yakubovskaya
Background. An in-depth study of the participation of the microbiota in the pathogenesis of tumors has opened up new opportunities for the development of alternative approaches to the diagnosis, therapy and prevention of malignant neoplasms.Aim. To summarize the data on the practical use of microbiota profile features as a marker of carcinogenesis and diagnosis, as well as to consider its participation in the combined treatment and prevention of cancer.Materials and methods. A literature search was carried out in the databases NCBI MedLine (PubMed), Scopus, web of Science using keywords that determine the purpose of the study. Results from original studies, meta-analyses, randomized controlled clinical trials, and traditional, systematic, and umbrella reviews published in recent years were analysed.Results. Qualitative and quantitative changes in the composition of the microbiota associated with the pathogenesis of oncological diseases make it possible to use them as markers for determining the risk of developing malignant neoplasms and predicting a wide range of tumors. The mechanisms that determine the use of the microbiota in anticancer therapy are diverse. The effect on the immune system is the most significant. Of great interest are artificially created hybrid nanoparticles covered with a membrane of bacterial vesicles and tumor cells to activate specific antitumor immunity. In terms of cancer prevention, the use of probiotics, prebiotics and synbiotics discovered by I.I. Mechnikov was fundamentally substantiated.Conclusion. The complex of scientific genomic and epigenetic data obtained in mechanistic and epidemiological studies on the role of the microbiota in the pathogenesis of tumors is currently evaluated as the most significant result justifying its practical application as a component of cancer diagnosis, therapy and prevention.

25 August 2024 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
LSL. G. Solenova
L. G. Solenova
NRN. I. Ryzhova
N. I. Ryzhova
IAIrina Antonova
Irina Antonova
GBGennady A. Belitsky
Gennady A. Belitsky
KKKirill Kirsanov
Kirill Kirsanov
MYMarianna G Yakubovskaya
Marianna G Yakubovskaya
The development of omics technologies and sequencing has significantly expanded the understanding of the role of microorganisms that inhabit various human organs and collectively make up its microbiota in the development of cancer. The extensive literature of recent years devoted to various aspects of the participation of the microbiota in carcinogenesis substantiates the relevance of analyzing the impact of its features on the processes of carcinogenesis in various human organs.   Purpose of the study. Analysis of literature data on the key issues of the relationship between the human microbiome and the risk of cancer and explore possible prospects for its use in the diagnosis, therapy and prevention of cancer. Materials and methods. A literature search was carried out in the databases NCBI MedLine (PubMed), Scopus, Web of Science, based on an extended list of keywords that included all the localizations of malignant neoplasms (MNs) considered in the review. Original studies, meta-analyses, randomized controlled trials, and reviews published in recent years were used. Results. Recent studies using omics technologies have shown significant differences in the composition of microbial communities of healthy and tumor tissues and have made it possible to characterize the potential tumor microbiota in some types of cancer. The microbiota present in the various organs of the human body forms a network through which it interacts via migration or by forming metabolic axes between organs. Dysbiosis plays an important role in carcinogenesis, and its presence in one organ can negatively affect the condition of other distant organs and contribute to the development of pathological conditions in them.   Conclusion. Numerous studies conducted over the past decade have revealed a complex relationship between microorganisms, tumors, and the host, reflecting the diverse effects of the microbiota on various organ- specific types of MNs. Gastrointestinal tract tumors, as well as sites outside it with significant bacterial associations, have been identified for a better understanding of the multifaceted mechanisms by which the microbiota influences cancer. The data obtained so far complement the emerging possibilities of using the microbiota in clinical practice, which represents a new approach to the prevention and treatment of malignant neoplasms.